| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.02 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |